Antifibrotic agent

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/70 (2006.01) A61K 31/737 (2006.01)

Patent

CA 2259773

An antifibrotic agent comprising a keratan sulfate oligosaccharide or a pharmaceutically acceptable salt thereof as an active ingredient. The antifibrotic agent is used as a prophylactic or a depressant for fibrosis accompanying one or more diseases preferably selected from the group consisting of pulmonary fibrosis, hepatocirrhosis, arteriosclerosis, scleroderma, restenosis of coronary artery after percutaneous transluminal coronary angioplasty (PTCA), interstitial myocarditis, interstitial cystitis, glomerulonephritis, angiitis, diabetic nephropathy, hypertensive nephrosclerosis, HIV nephropathy, IgA nephropathy, lupus nephritis, interstitial nephritis, obstructed kidney due to ureteral obstruction, skin scar formation after burn, and toxicosis.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antifibrotic agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antifibrotic agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antifibrotic agent will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1829473

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.